The 3rd "NeoSilk Path" on International Advanced Training Course in Colorectal Surgery Concludes Successfully!

The 3rd "NeoSilk Path" on International advanced training course in colorectal surgery , hosted by Bluesail Surgical, concluded triumphantly on March 1, 2025, after a seven-day event spanning February 23 to March 1.

This gathering united scholars from Romania, South Africa, Uzbekistan, Malaysia, and Taiwan, China, creating a platform for international camaraderie, academic collaboration, and knowledge dissemination.

First Stop: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Founded in 1907 as Guangci Hospital, Ruijin Hospital is a top-tier comprehensive teaching hospital. It has earned the highest national rating (A++) in public hospital performance evaluations for five consecutive years and has been honored as a "National Civilized Unit" six times.

As a pioneer in high-quality development, Ruijin Hospital is among the first national pilot institutions for modern hospital management systems and a key emergency medical rescue base. It is also part of the National Medical Center (Comprehensive Category) initiative and serves as the National Regional Medical Center through its Hainan branch.

Overview of the First Stop Conference

On February 24, colorectal specialists from Romania, South Africa, Uzbekistan, Malaysia, and Taiwan, China, began a two-day exchange at Ruijin Hospital.

Prof. Minhua Zheng from Ruijin Hospital delivered a welcoming speech, extending heartfelt greetings to the visiting physicians and introducing the hospital’s advancements in minimally invasive surgery.

Under the guidance of Prof. Luyang Zhang , the international delegation toured the hospital’s wards, facilities, and its century-old museum, which chronicles Ruijin’s 170-year journey and China’s evolving medical technology.

During the surgical observation session on February 24, Prof. Zheng’s team demonstrated laparoscopic techniques for colon and rectal cancer surgeries, emphasizing sphincter preservation. Prof. Zheng meticulously explained procedural approaches, lymph node dissection, and digestive tract reconstruction, sparking in-depth discussions on global treatment practices.

On February 25, Prof. Zheng’s team led a seminar on hot topics in colorectal surgery, including laparoscopic right hemicolectomy, different approaches and lymphadenectomy, total laparoscopic digestive tract reconstruction in laparoscopic colonic surgery from the perspective of mesenteric anatomny, and surgical decision-making for MSI-high rectal cancer. The interactive session was met with enthusiastic engagement.

Second Stop: Sun Yat-sen University Cancer Center

Established in March 1964, Sun Yat-sen University Cancer Center (SYSUCC) is one of China’s earliest oncology hospitals. As a leading hub for cancer treatment, research, and prevention, SYSUCC plays a pivotal role in national and regional oncology care, particularly in South China and the Greater Bay Area.

SYSUCC houses key platforms such as the State Key Laboratory of Oncology in South China, the National Clinical Trial Center for Anticancer Drugs, and the Guangdong Cancer Center. Its flagship journal, Cancer Communications, holds significant international influence.

Overview of the Second Stop Conference

On February 27, Prof. Ruihua Xu, Director of SYSUCC, inaugurated the event. Prof. Zhizhong Pan and Prof. Peirong Ding, leading colorectal surgeons, extended warm welcomes, emphasizing the goal of fostering innovation and global collaboration in colorectal cancer care.

The same day, SYSUCC experts including Prof. Pan, Prof. Ding, Prof. Liren Li, Prof. Xiaojun Wu, Prof. Junzhong Lin, Prof Gong Chen and Prof Zhenhai Lu, performed multiple colorectal surgeries. The live demonstrations of robotic and laparoscopic colorectal surgeries were complemented by detailed technical explanations and dynamic exchanges with international delegates.

On February 28, after observing clinical workflows, Prof. Ding outlined the department’s evolution. Prof. Feng Wang, Prof Gong Chen, Prof. Wu Jiang, and Prof. Binyi Xiao delivered keynote speeches on innovative therapies and minimally invasive techniques, showcasing SYSUCC’s groundbreaking research in colorectal oncology.

Topics included SYSUCC’s colorectal cancer studies, research progress on MRD in colorectal cancer, screening and management for Lynch syndrome, and SYSUCC clinical research on immunotherapy for dMMR/MSI-H colorectal cancer.

International participants praised the event for deepening their understanding of China’s surgical expertise and expressing eagerness for future collaborations.

During surgery observation sessions, Bluesail Surgical's Siderlux® Powered Articulating Endoscopic Linear Cutter was extensively utilized in various surgeries. Different models of stapling cartridges are designed for various tissue thicknesses, and the staple formation guiding technology improves closure. When it comes to cutting and closing the colorectal tissue, the instrument effectively reduces bleeding, making it an ideal surgical instrument.

Event Summary

This seven-day academic odyssey showcased China’s cutting-edge advancements in colorectal surgery, setting new global benchmarks and heralding future trends in medical technology.

Bluesail Surgical remains committed to fostering global partnerships. We believe that international collaboration will unlock novel solutions to surgical challenges, driving continuous progress in global healthcare.

The "NeoSilk Path" is both a tribute to ancient trade routes and a bridge to the future—a symbol of mutual growth and shared prosperity. In this era of globalization, Bluesail Surgical stands at the forefront, striving to build robust alliances with experts worldwide.

Through platforms like this, we aim to unite global minds, address critical challenges, and steer the ship of surgical innovation toward a brighter horizon.

With unwavering resolve, Bluesail Surgical will continue pioneering a unique path of mutual benefit along the "NeoSilk Path", sowing seeds of hope and reaping fruits of health for all humanity.